Sponsor-Investigators

Dwight Owen

BTCRC-LUN20-462

A Randomized, Multi-Cohort Phase II Trial of Temozolomide and Atezolizumab as Second Line Treatment for Small Cell Lung Cancer

Status

Cancer Types

Lung

Locations

Indiana University Melvin and Bren Simon Comprehensive Cancer Center, The Ohio State University, University of Illinois Cancer Center, University of Iowa Holden Comprehensive Cancer Center, University of Wisconsin Carbone Cancer Center